Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial

Cancer Communications

Young-Jun Eum¹  Jin-Soo Kim²  Hwan-Jung Yun³  Yong Sang Hong⁴  Kyung-Hee Lee⁴  Min Kyoung Kim⁴  Jin-Seok Ahn⁵  Jung-Hun Kang⁶  Gyeong-Won Lee⁷  Tae Won Kim⁷  Jeong Eun Kim⁷  Sun-Young Kim⁸  Sung Ae Koh⁹ 

[1]Department of Hematology-Oncology, Chungnam National University Hospital, Daejeon, South Korea

[2]Department of Hematology-Oncology, Gyeongsang National University Hospital, Jinju, South Korea

[3]Department of Hematology-Oncology, National Cancer Center, Ilsan, South Korea

[4]Department of Hematology-Oncology, Yeungnam University Medical Center, Daegu, South Korea

[5]Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, South Korea

[6]Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

[7]Department of Oncology, Asan Medical Center, University of Ulsan, Seoul, South Korea

[8]Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, South Korea

[9]Medical Affairs, Mundipharma Korea Ltd, Seoul, South Korea

关键词: Constipation;    Naloxone;    Oxycodone;    Quality of life;    Safety;   

DOI  :  10.1186/s40880-017-0241-4

学科分类：肿瘤学

来源: Springer

【 授权许可】

CC BY